Loading company…
Symetis develops heart valve devices for transcatheter aortic valve implantation procedures.
Founded in 2001 and based in Ecublens, Switzerland, Symetis developed medical devices for transcatheter aortic valve implantation. Its products included the Acurate neo valve for treating severe aortic stenosis. Boston Scientific acquired the company for USD 435 mn in March 2017, with the deal completed in May 2017.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in